Shuttle Pharmaceuticals Holdings (SHPH) Non-Current Deferred Tax Liability (2022 - 2025)

Shuttle Pharmaceuticals Holdings' Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $2485.0 for Q4 2025.

• On a quarterly basis, Non-Current Deferred Tax Liability rose 25.82% year-over-year to $2485.0 in Q4 2025; TTM through Dec 2025 was $2485.0, a 25.82% increase from a year earlier, with the FY2025 full-year figure at $2485.0, up 25.82% from the prior year.
• Non-Current Deferred Tax Liability rose to $2485.0 in Q4 2025 per SHPH's latest filing, from $1975.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $3.5 million in Q4 2023 and bottomed at $1975.0 in Q4 2024.
• The 4-year median for Non-Current Deferred Tax Liability is $54699.5 (2022), against an average of $907214.8.
• Across the five-year window, Non-Current Deferred Tax Liability surged 3190.01% in 2023 and sank 99.94% in 2024, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $106914.0 in 2022, then jumped by 3190.01% to $3.5 million in 2023, then sank by 99.94% to $1975.0 in 2024, then grew by 25.82% to $2485.0 in 2025.
• Per Business Quant, the three latest SHPH Non-Current Deferred Tax Liability figures stand at $2485.0 (Q4 2025), $1975.0 (Q4 2024), and $3.5 million (Q4 2023).